To download click here

The patent protects a new class of cancer vaccines rolling off the Moditope platform

[View article]

To download click here

To download click here

In a separate announcement, the company said it was acquiring new technology from Nottingham University that will complement its current pipeline

[View article]

Cliff Holloway, chief executive at Scancell Holdings Plc (LONSCLP), tells Proactive Investors they're raising up to £8mln through a placing and open offer – cash that will be used develop their three main drug candidates.

A placing and subscription at 12 pence a share will account for £6mln of the total.

The company also wants to include existing investors, so is planning a £2mln open offer of stock once the placing has been concluded.

[View interview]

To download click here

To download click here

To download click here

The AIM-listed firm said its Moditope platform acts by stimulating the production of CD4+ T cells, which seek out and kill tumour cells that would otherwise be hidden from the immune system

[View article]